selegiline has been researched along with glutamic acid in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (58.82) | 18.2507 |
2000's | 3 (17.65) | 29.6817 |
2010's | 3 (17.65) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Hayashi, S; Kato, A; Mizuno, K; Morita, A; Nakata, E; Ohashi, K; Yamamura, K | 1 |
Marini, AM; Paul, SM; Weller, M | 1 |
Lillrank, S; Oja, SS; Saransaari, P; Suhonen, J | 1 |
Boulu, RG; Callebert, J; Lancelot, E; Plotkine, M | 1 |
Chan, P; Di Monte, DA; Langston, JW | 1 |
Gerlach, M; Riederer, P; Youdim, MB | 1 |
Davis, JB; Maher, P | 1 |
Krieglstein, J; Schilling, M; Semkova, I; Wolz, P | 1 |
Oliveira, CR; Pereira, CM | 1 |
Ferger, B; Kuschinsky, K; Seyfried, C; van Amsterdam, C | 1 |
Kondakova, LI; Medvedev, AE; Moskvitina, TA; Navasardyantz, DG; Podobed, OV; Tsvetkova, TA; Yakusheva, IV | 1 |
Brekke, L; Ebadi, M; Sangchot, P; Sharma, S; Shavali, S | 1 |
Fujimaru, S; Matsubara, K; Ohtaki, K; Saito, O; Shimizu, K; Shiono, H | 1 |
Haapalinna, A; Niittykoski, M; Sirviö, J | 1 |
Kesby, JP; Markou, A; Semenova, S | 1 |
Baghy, K; Knoll, J; Mervai, Z; Miklya, I; Timar, J; Zelena, D | 1 |
1 review(s) available for selegiline and glutamic acid
Article | Year |
---|---|
Is selegiline neuroprotective in Parkinson's disease?
Topics: Animals; Brain; Clinical Trials as Topic; Enzyme Induction; Glutamic Acid; Humans; Hydrogen Peroxide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotoxins; Parkinson Disease; Selegiline; Superoxide Dismutase | 1994 |
16 other study(ies) available for selegiline and glutamic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: de
Topics: Analgesics; Animals; Benzimidazoles; Drug Design; Drug Evaluation, Preclinical; Humans; Microsomes, Liver; Neuralgia; Nociceptin Receptor; Pyrroles; Rats; Receptors, Opioid; Structure-Activity Relationship | 2010 |
Niacinamide blocks 3-acetylpyridine toxicity of cerebellar granule cells in vitro.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cerebellum; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Mazindol; N-Methylaspartate; Neurons; Niacinamide; Pyridines; Rats; Rats, Sprague-Dawley; Selegiline; Tetrahydrofolates | 1992 |
Effects of long-term treatment with a monoamine oxidase B inhibitor, selegeline (L-deprenyl), on amino acid transmitter systems in the ageing rat brain.
Topics: Aging; Animals; Brain Chemistry; Dizocilpine Maleate; Glutamic Acid; In Vitro Techniques; Male; Membranes; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, GABA-A; Receptors, GABA-B; Receptors, N-Methyl-D-Aspartate; Selegiline | 1995 |
Striatal dopamine participates in glutamate-induced hydroxyl radical generation.
Topics: Animals; Clorgyline; Dopamine; Glutamic Acid; Hydroxyl Radical; Male; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley; Salicylates; Selegiline | 1995 |
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on levels of glutamate and aspartate in the mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Aspartic Acid; Brain Chemistry; Deoxyglucose; Energy Metabolism; Glutamic Acid; Male; Mazindol; Mice; Mice, Inbred C57BL; Receptors, N-Methyl-D-Aspartate; Selegiline | 1994 |
The role of monoamine metabolism in oxidative glutamate toxicity.
Topics: Amines; Animals; Cells, Cultured; Clorgyline; Dose-Response Relationship, Drug; Glutamic Acid; Mice; Mice, Inbred Strains; Monoamine Oxidase; Selegiline | 1996 |
Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage.
Topics: Animals; Animals, Newborn; Astrocytes; Brain Ischemia; Cells, Cultured; Cerebral Cortex; Glutamic Acid; Hippocampus; Immunohistochemistry; Male; Mice; Nerve Growth Factors; Neurons; Neuroprotective Agents; Rats; Rats, Inbred F344; RNA, Messenger; Selegiline | 1996 |
Glutamate toxicity on a PC12 cell line involves glutathione (GSH) depletion and oxidative stress.
Topics: Animals; Antioxidants; Benzoquinones; Cell Death; Cystine; Dithiothreitol; Glutamic Acid; Glutathione; Glutathione Reductase; Kinetics; L-Lactate Dehydrogenase; Oxidative Stress; PC12 Cells; Rats; Selegiline; Ubiquinone; Vitamin E | 1997 |
Effects of alpha-phenyl-tert-butylnitrone and selegiline on hydroxyl free radicals in rat striatum produced by local application of glutamate.
Topics: Administration, Topical; Animals; Corpus Striatum; Cyclic N-Oxides; Free Radical Scavengers; Gentisates; Glutamic Acid; Hydroxybenzoates; Hydroxyl Radical; Male; Microdialysis; Monoamine Oxidase Inhibitors; Nitrogen Oxides; Rats; Rats, Wistar; Selegiline | 1998 |
Modulation of glutamate neurotoxicity in the transformed cell culture by monoamine oxidase inhibitors, clorgyline and deprenyl.
Topics: Animals; Cell Division; Cell Line, Transformed; Cell Survival; Clorgyline; DNA, Neoplasm; Glioma; Glutamic Acid; Kinetics; L-Lactate Dehydrogenase; Monoamine Oxidase Inhibitors; Neurotoxins; Rats; Selegiline; Time Factors; Tumor Cells, Cultured | 1998 |
The multiple actions of selegiline.
Topics: Animals; Antiparkinson Agents; Cells, Cultured; Dopamine; Female; Glutamic Acid; Mesencephalon; Monoamine Oxidase Inhibitors; MPTP Poisoning; Neurons; Neuroprotective Agents; Parkinson Disease; Pregnancy; Rats; Rats, Sprague-Dawley; Selegiline | 2002 |
Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Extracellular Space; Glutamic Acid; Herbicides; Homovanillic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Motor Activity; Nerve Tissue Proteins; Neuroprotective Agents; Neurotoxins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Paraquat; Parkinsonian Disorders; Quinoxalines; Rats; Rats, Wistar; Selegiline | 2003 |
Selegiline reduces N-methyl-D-aspartic acid induced perturbation of neurotransmission but it leaves NMDA receptor dependent long-term potentiation intact in the hippocampus.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Monoamine Oxidase Inhibitors; N-Methylaspartate; Neurons; Pargyline; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Selegiline; Synaptic Transmission | 2003 |
Effects of HIV/TAT protein expression and chronic selegiline treatment on spatial memory, reversal learning and neurotransmitter levels in mice.
Topics: Animals; Brain; Dopamine; Gene Expression; Gene Products, tat; Glutamic Acid; Glutamine; HIV; Male; Maze Learning; Mental Recall; Mice, Inbred C57BL; Mice, Transgenic; Monoamine Oxidase Inhibitors; Reversal Learning; Selegiline; Serotonin; Spatial Memory | 2016 |
Synthetic enhancer compounds, besides acting on biogenic amine system, influence the glutamate transmission and stress response.
Topics: Animals; Anxiety; Behavior, Animal; Benzofurans; Corticosterone; Disease Models, Animal; Drug Synergism; Glutamic Acid; Male; Maze Learning; Neurotransmitter Agents; Rats; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Selegiline; Stress, Psychological | 2020 |